Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,812.55
39.45 (2.22%)
BSENSE

May 06

BSE+NSE Vol: 3.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,812.55",
    "chg": 39.45,
    "chgp": "2.22%",
    "dir": 1,
    "prev_price": "1,773.10",
    "mcapval": "29,425.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE068V01023",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "3.78 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-3976991",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3976991.png",
        "date": "2026-05-06 08:06:14",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on weekly charts, despite a recent 2.43% decline in its share price. This nuanced change is underscored by a complex interplay of technical indicators, reflecting both optimism and caution among investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3974989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3974989.png",
        "date": "2026-05-05 08:07:29",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. This transition comes amid a strong price performance that outpaces the broader Sensex, signalling renewed investor interest in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3973813",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3973813.png",
        "date": "2026-05-04 08:02:31",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite this, key indicators such as the MACD and KST suggest a nuanced outlook, with weekly signals showing mild bullishness contrasting with monthly bearish tendencies. This complex technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3972597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_mojoScore_3972597.png",
        "date": "2026-05-02 10:10:25",
        "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts to Sideways; Hold Rating Upgraded",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-to-sideways-hold-rating-upgraded-3965705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3965705.png",
        "date": "2026-04-28 08:06:01",
        "description": "Gland Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend, reflecting a cautious optimism among investors. The stock’s recent 3.44% gain to ₹1,773.30, coupled with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggests a complex interplay of bullish and bearish forces shaping its near-term trajectory."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3963709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3963709.png",
        "date": "2026-04-27 08:02:44",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of late April 2026. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s mixed technical indicators and price action suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3955812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_mojoScore_3955812.png",
        "date": "2026-04-21 10:10:33",
        "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3955153",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3955153.png",
        "date": "2026-04-21 08:06:12",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day decline of 0.50%, the stock’s recent performance and technical signals suggest a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3950146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3950146.png",
        "date": "2026-04-17 08:04:08",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of April 2026. Despite a recent downgrade in technical trend, the stock’s fundamental performance and mixed indicator signals suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 375,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Clarification With Respect To The Announcement Made On 13Th April 2026 Regarding Postal Ballot Notice",
      "datetime": "27-Apr-2026",
      "details": "Clarification with respect to the Announcement made on 13th April 2026 regarding Postal Ballot Notice",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And To Consider And Recommend Payment Of Final Dividend If Any For The Financial Year Ended March 31 2026",
      "datetime": "21-Apr-2026",
      "details": "Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and financial year ended March 31 2026 and to consider and recommend payment of Final Dividend if any for the financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "21-Apr-2026",
      "details": "Q4FY26 Earnings Call Intimation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "15 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Clarification With Respect To The Announcement Made On 13Th April 2026 Regarding Postal Ballot Notice

27-Apr-2026 | Source : BSE

Clarification with respect to the Announcement made on 13th April 2026 regarding Postal Ballot Notice

Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And To Consider And Recommend Payment Of Final Dividend If Any For The Financial Year Ended March 31 2026

21-Apr-2026 | Source : BSE

Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and financial year ended March 31 2026 and to consider and recommend payment of Final Dividend if any for the financial year ended March 31 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

21-Apr-2026 | Source : BSE

Q4FY26 Earnings Call Intimation

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

15 May 2026

stock-summary
DIVIDEND

Gland Pharma Ltd has declared 1800% dividend, ex-date: 14 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available